Cerevel Therapeutics
CERE
$40.74
Share price
0.25%
Change (1 day)
25.16%
Change (1 year)
Categories
Cerevel Therapeutics (CERE) - P/B ratio
P/B ratio as of June 2024 : 13.2
According to Cerevel Therapeutics's latest financial reports the company has a price-to-book ratio of 13.2.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Cerevel Therapeutics - P/B ratio (from 2020 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 11.4 | 20.18% |
| 2022-12-31 | 9.46 | 14.68% |
| 2021-12-31 | 8.25 | 50.47% |
| 2020-12-31 | 5.48 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | 1.26 | -90.41% | 🇺🇸 USA |
 Campbell Soup CPB | 3.37 | -74.40% | 🇺🇸 USA |
 Dow DOW | 2.13 | -83.81% | 🇺🇸 USA |
 Dupont De Nemours DD | 1.42 | -89.19% | 🇺🇸 USA |